CIK 0002007919
- Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 990613523
- Phone
- +1 858-795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- 4 Open-market buy Director bought 57,549 shares at an average $17.32 ($997,024)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 286,786 shares at an average $17.18 ($4,927,580)
- 4 Other disposition 10% owner disposed of 13,316,140 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 761,413 shares (grant or award)
- 4 Grant or award Director acquired 818,575 shares (grant or award)
- 4 Grant or award Director acquired 149,564 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 513,888 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 3 · 59 filings